1.A Review of Clinical Research on Heterotopic Gastric Mucosa of the Upper Esophagus
Chinese Journal of Gastroenterology 2016;(1):62-64
Heterotopic gastric mucosa of the upper esophagus( HGMUE)is a rare esophageal disease. It is considered as a result of immature development of esophageal mucosal epithelium in embryonic period. Most of patients have no specific symptoms. The diagnosis of HGMUE is mainly based on endoscopy and biopsy. With the development of endoscopic technique,the detection rate of HGMUE is elevated and increasing attention has been paid to this disease. This article reviewed the clinical research on HGMUE.
2.Hypolipemic treatment of hyperlipidemic pancreatitis with enema
Yunxing SHI ; Jiao Lü ; Guozhong ZHOU ; Yongping LI ; Changyun LIU ; Linhua QIN ; Zhiwu ZHENG
International Journal of Traditional Chinese Medicine 2010;32(3):247-248
Objective To investigate hypolipemic treatment of hyperlipidemic panereatiti(HLP)with integrated traditional Chinese and western medicine.Methods Cinical data of 20 patients of HLP were analyzed retrospectively.Eight patients in the control group were treated with conventional therapies,while 12 patients in the treatment group were treated as follows:①Enema with 180ml solution(50% magnesium sulfate 30 ml.Glycerin 60ml,water 90ml).②Rhubarb gastrogavage with 9 g tid.③Intravenous drip with 24 g salvia miltiorrhiza qd.Results The treatment group had significant difference comparing with the control group in terms of the serum TG in 48 hours(P<0.01),time of autonomous bowel movement recover(P<0.01),days of abdominal pain disappear(P<0.05),days of hospitalization(P<0.01).Conclusion The treatment of Enema with 180 ml solution.Rhubarb gastrogavage with 9g tid,and Intravenous drip with 24 g salvia miltiorrhiza qd can relieve the symptoms of HLP and decrease blood-fat greatly.
3.Andrographolide inhibits extracellular signal-regulated kinase 1/2 signaling pathway in activated macrophages.
Linhua QIN ; Jiao Lü ; Lin KONG ; Yunxing SHI ; Yongping LI ; Guozhong ZHOU ; Zhiwu ZHENG ; Lin LI ; Xingying JI
Journal of Integrative Medicine 2011;9(6):632-637
Objective: To investigate the effects of andrographolide on extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway and tumor necrosis factor-α (TNF-α) expression in lipopolysaccharide (LPS)-activated macrophages. Methods: LPS-activated mouse peritoneal macrophages were cultured in media with different concentrations of andrographolide. Cytotoxicity of andrographolide was detected by cell counting kit-8. The macrophages were lysed, and then expressions of phosphorylated ERK1/2, JNK and p38 and nuclear factor-κB inhibitor (IκBα) protein were detected by Western blotting and TNF-α mRNA expression was detected by reverse transcription-polymerase chain reaction. Supernatants of the macrophages were used to detect content of TNF-α protein by enzyme-linked immunosorbent assay. Results: Andrographolide at 1-100 μg/mL showed no cytotoxicity on LPS-activated mouse peritoneal macrophages. Andrographolide inhibited ERK1/2 phosphorylation in LPS-activated murine peritoneal macrophages, which was concentration-dependent (P<0.01). Andrographolide at 1-25 μg/mL had no effects on phosphorylation levels of JNK and p38 and IκBα degradation in LPS-stimulated mouse peritoneal macrophages. In activated macrophages, TNF-α expression was inhibited by 12 μg/mL andrographolide and 20 μmol/L PD98059 (inhibitor of ERK1/2 signaling pathway) at both mRNA expression and protein secretion levels. Conclusion: In LPS-activated macrophages, andrographolide may inhibit the expression of TNF-α by inhibiting ERK1/2 signaling pathway.